Yale will enroll patients in smoking cessation study combining nicotine patch and naltrexone.

0 Comments | M2 Presswire, May, 2001

M2 PRESSWIRE-1 May 2001-YALE UNIVERSITY: Yale will enroll patients in smoking cessation study combining nicotine patch and naltrexone (C)1994-2001 M2 COMMUNICATIONS LTD RDATE:01052001 New Haven, Conn. -- Cigarette smokers interested in quitting are invited to join a six-week, research treatment study at Yale School of Medicine that combines the nicotine patch and naltrexone, a medication used to help fight addictions.

All participants will receive the patch and naltrexone, or a placebo. Naltrexone is what is known as an opiate antagonist, which means it is a medication that works to block the effects of opiates in the brain. The study is being conducted as part of the Transdisciplinary Tobacco Use Research Center (TTURC) at Yale, which is one of...